Paper - WANFANG MED ONLINE

You Position: Home > Paper

Morphology of the anterior mesorectum: a new predictor for local recurrence in patients with rectal cancer

( views:0, downloads:0 )

Author:: No author available

Journal Title:: Chinese Medical Journal

Issue:: 20

DOI:: 10.1097/CM9.0000000000002024

Key Word:: Local recurrence;Magnetic resonance imaging;Morphology of the anterior mesorectum;Rectal cancer;Local recurrence;Magnetic resonance imaging;Morphology of the anterior mesorectum;Rectal cancer

Abstract： Background::Pre-operative assessment with high-resolution magnetic resonance imaging (MRI) is useful for assessing the risk of local recurrence (LR) and survival in rectal cancer. However, few studies have explored the clinical importance of the morphology of the anterior mesorectum, especially in patients with anterior cancer. Hence, the study aimed to investigate the impact of the morphology of the anterior mesorectum on LR in patients with primary rectal cancer.Methods::A retrospective study was performed on 176 patients who underwent neoadjuvant treatment and curative-intent surgery. Patients were divided into two groups according to the morphology of the anterior mesorectum on sagittal MRI: (1) linear type: the anterior mesorectum was thin and linear; and (2) triangular type: the anterior mesorectum was thick and had a unique triangular shape. Clinicopathological and LR data were compared between patients with linear type anterior mesorectal morphology and patients with triangular type anterior mesorectal morphology.Results::Morphometric analysis showed that 90 (51.1%) patients had linear type anterior mesorectal morphology, while 86 (48.9%) had triangular type anterior mesorectal morphology. Compared to triangular type anterior mesorectal morphology, linear type anterior mesorectal morphology was more common in females and was associated with a higher risk of circumferential resection margin involvement measured by MRI (35.6% [32/90] vs. 16.3% [14/86], P = 0.004) and a higher 5-year LR rate (12.2% vs. 3.5%, P = 0.030). In addition, the combination of linear type anterior mesorectal morphology and anterior tumors was confirmed as an independent risk factor for LR (odds ratio = 4.283, P = 0.014). Conclusions::The classification established in this study was a simple way to describe morphological characteristics of the anterior mesorectum. The combination of linear type anterior mesorectal morphology and anterior tumors was an independent risk factor for LR and may act as a tool to assist with LR risk stratification and treatment selection.

Reference

[1]Kraima, A. C.,West, N. P.,Treanor, D.,etc.Understanding the surgical pitfalls in total mesorectal excision: Investigating the histology of the perirectal fascia and the pelvic autonomic nerves[J].2015,41(12).
[2]Qi Liu,Dakui Luo,Sanjun Cai,etc.Circumferential resection margin as a prognostic factor after rectal cancer surgery: A large population‐based retrospective study[J].2018,7(8).
[3]L, Roncucci.Local recurrences of rectal cancer.[J].2005,60.
[4].The impact of circumferential tumour location on the clinical outcome of rectal cancer patients managed with neoadjuvant chemoradiotherapy followed by total mesorectal excision[J].2020,46(6).
[5]E, Syk,M R, Torkzad,L, Blomqvist,etc.Radiological findings do not support lateral residual tumour as a major cause of local recurrence of rectal cancer.[J].2006,93(1).
[6].Does circumferential tumor location affect the circumferential resection margin status in mid and low rectal cancer?[J].2018,41(3).
[7]Homan, J.,Bokkerink, G. M.,Aarts, M. J.,etc.Variation in circumferential resection margin: Reporting and involvement in the South-Netherlands[J].2015,41(11).
[8]Bujko K,Kolodziejczyk M,Nasierowska Guttmejer A,etc.Tumour regression grading in patients with residual rectal cancer after preoperative chemoradiation.[J].2010,95(3).
[9]S, Bülow,I J, Christensen,H, Harling,etc.Recurrence and survival after mesorectal excision for rectal cancer.[J].2003,90(8).
[10]B K,Dassanayake.Local recurrence of rectal cancer in patients not receiving neoadjuvant therapy - the importance of resection margins.[J].2011,56.
[11]Hong, Theodore S.,Ryan, David P..Adjuvant Chemotherapy for Locally Advanced Rectal Cancer: Is It a Given?[J].2015,33(17).
[12]Bin Lu,Na Li,Chen-Yu Luo,etc.Colorectal cancer incidence and mortality:the current status, temporal trends and their attributable risk factors in 60 countries in 2000-2019[J].2021,134(16).
[13]Peeters Koen C.M.J.,Marijnen Corrie A.M.,Nagtegaal Iris D.,etc.The TME Trial After a Median Follow-up of 6 Years[J].2007.
[14]Torkzad MR,Blomqvist L.The mesorectum: morphometric assessment with magnetic resonance imaging.[J].2005,15(6).
[15]Blunt DM,Gada V,Allen SD.Variation of mesorectal volume with abdominal fat volume in patients with rectal carcinoma: assessment with MRI.[J].2007,80(952).
[16]Giercksky KE,Wiig JN,Wolff PA,etc.Location of pelvic recurrence after 'curative' low anterior resection for rectal cancer.[J].1999,25(6).
[17]Martling A,Holm T,Bremmer S,etc.Prognostic value of preoperative magnetic resonance imaging of the pelvis in rectal cancer.[J].2003,90(11).
[18]Fiona G.M. Taylor,Philip Quirke,Richard}. Heald,etc.Preoperative Magnetic Resonance Imaging Assessment of Circumferential Resection Margin Predicts Disease-Free Survival and Local Recurrence: 5-Year Follow-Up Results of the MERCURY Study[J].2014,32(1).
[19]van-de-Velde CJ,Steup WH,Wiggers T,etc.Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer.[J].2001,345(9).
[20]Victoria C. Banwell,Hamish A. Phillips,Michael J. Duff,etc.Five-year oncological outcomes after selective neoadjuvant radiotherapy for resectable rectal cancer[J].2019,58(9).
[21]Marcel, den Dulk,Corrie A M, Marijnen,Hein, Putter,etc.Risk factors for adverse outcome in patients with rectal cancer treated with an abdominoperineal resection in the total mesorectal excision trial.[J].2007,246.
[22]C L H, Chan,E L, Bokey,P H, Chapuis,etc.Local recurrence after curative resection for rectal cancer is associated with anterior position of the tumour.[J].2006,93(1).
[23]Malakorn, Songphol,Yang, Yun,Bednarski, Brian K.,etc.Who Should Get Lateral Pelvic Lymph Node Dissection After Neoadjuvant Chemoradiation?[J].2019,62(10).
[24]Yang Yong,Wang Han-Yang,Chen Yong-Kang,etc.Current status of surgical treatment of rectal cancer in China[J].2020,133(22).
[25]Kevin F, Birbeck,Christopher P, Macklin,Nicholas J, Tiffin,etc.Rates of circumferential resection margin involvement vary between surgeons and predict outcomes in rectal cancer surgery.[J].2002,235.
[26]Yoon, Jiyoung,Chung, Yong Eun,Lim, Joon Seok,etc.Quantitative assessment of mesorectal fat: new prognostic biomarker in patients with mid-to-lower rectal cancer[J].2019,29(3).
[27].Correlation Between Endorectal Ultrasound and Magnetic Resonance Imaging for Predicting the Circumferential Resection Margin in Patients With Mid‐Low Rectal Cancer Without Preoperative Chemoradiotherapy[J].2020,39(3).
[28]Sagar PM,Boyle KM,Finan PJ,etc.Morphology of the mesorectum in patients with primary rectal cancer.[J].2009,52(6).
[29]Yanhui, Jiang,Kaiyun, You,Xingsheng, Qiu,etc.Tumor volume predicts local recurrence in early rectal cancer treated with radical resection: A retrospective observational study of 270 patients.[J].2017,49(Spec ).